Donaldson
DCI
87.26
-2.85
-3.16%
Donaldson
US · DCI
#1444 by market cap
Listed 1970
87.26
-2.85
-3.16%
Live - 5344 symbols - heartbeat 252s ago
· 2026-10-07 19:54
After-hours
87.26
0.00%
- Market cap
- 10.11B
- P/E (TTM)i
- 22.66
- P/Bi
- 5.73
- EPSi
- 3.85
- Div yieldi
- 1.40%
- 52W posi
- 25%
Reader sentiment
Are you bullish or bearish on DCI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.48, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +5.28% YoY
Margins
- Gross margin
- 34.64%
- Operating margin
- 15.20%
- Net margin
- 11.68%
Key ratios & quality
- Enterprise valuei
- 11.18B
- PEG ratioi
- 2.78
- Altman Z-Scorei
- 5.48
PEG uses trailing P/E against the 3-year net income growth rate (8.14%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.84B | 2.58B | 2.85B | 3.31B | 3.43B | 3.59B | 3.69B | 3.89B |
| Gross profit | 948.30M | 871.60M | 971.70M | 1.07B | 1.16B | 1.27B | 1.29B | 1.35B |
| Selling & admin expenses | 497.80M | 470.30M | 519.20M | 554.80M | 602.30M | 636.70M | 642.20M | 679.20M |
| Research & development | 62.30M | 61.20M | 67.80M | 69.10M | 78.10M | 93.60M | 87.80M | 76.10M |
| Operating profit | 388.20M | 340.10M | 384.70M | 443.50M | 480.20M | 544.10M | 556.20M | 590.60M |
| Pretax profit | 375.20M | 335.20M | 381.00M | 438.40M | 468.70M | 535.30M | 492.20M | 585.80M |
| Tax | 108.00M | 78.20M | 94.10M | 105.60M | 109.90M | 121.30M | 125.20M | 132.00M |
| Net profit | 267.20M | 257.00M | 286.90M | 332.80M | 358.80M | 414.00M | 367.00M | 453.80M |
| Basic EPS | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 |
| Diluted EPS | 2.05 | 2.00 | 2.24 | 2.66 | 2.90 | 3.38 | 3.05 | 3.85 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 940.10M | 980.70M | 935.40M | 896.30M | 995.10M | 1.06B |
| Gross profit | 321.90M | 338.80M | 328.80M | 299.80M | 333.40M | 383.90M |
| Selling & admin expenses | 152.30M | 164.60M | 169.60M | 162.50M | 158.90M | 188.20M |
| Research & development | 21.40M | 22.50M | 19.20M | 18.60M | 19.20M | 19.10M |
| Operating profit | 148.20M | 151.70M | 140.00M | 118.70M | 155.30M | 176.60M |
| Pretax profit | 87.00M | 149.70M | 147.50M | 116.60M | 154.80M | 166.90M |
| Tax | 29.20M | 35.40M | 33.60M | 24.10M | 36.70M | 37.60M |
| Net profit | 57.80M | 114.30M | 113.90M | 92.50M | 118.10M | 129.30M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.48 | 0.97 | 0.97 | 0.78 | 1.00 | 1.10 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.12B | 1.10B | 1.24B | 1.41B | 1.29B | 1.44B | 1.46B | 1.67B |
| Cash & ST investments | 177.80M | 236.60M | 222.80M | 193.30M | 187.10M | 232.70M | 180.40M | 250.40M |
| Inventory | 332.80M | 322.70M | 384.50M | 502.40M | 418.10M | 476.70M | 513.60M | 538.70M |
| Total assets | 2.14B | 2.24B | 2.40B | 2.60B | 2.77B | 2.91B | 2.98B | 3.99B |
| Total current liabilities | 482.90M | 406.80M | 606.60M | 629.60M | 756.40M | 782.50M | 757.20M | 804.10M |
| Short-term debt | 52.30M | 35.20M | 48.50M | 3.70M | 159.10M | 53.30M | 37.90M | 44.80M |
| Long-term debt | 584.40M | 617.40M | 461.00M | 644.30M | 496.60M | 483.40M | 630.40M | 1.28B |
| Total liabilities | 1,249,900,000.00 | 1,251,700,000.00 | 1,263,100,000.00 | 1,467,100,000.00 | 1,449,800,000.00 | 1,425,200,000.00 | 1,523,700,000.00 | 2,222,400,000.00 |
| Total equity | 892.70M | 992.90M | 1.14B | 1.13B | 1.32B | 1.49B | 1.45B | 1.76B |
| Retained earnings | 1.28B | 1.43B | 1.61B | 1.85B | 2.09B | 2.38B | 2.61B | 2.92B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 1.48B | 1.46B | 1.51B | 1.53B | 1.57B | 1.67B |
| Cash & ST investments | 178.50M | 180.40M | 210.70M | 194.40M | 204.10M | 250.40M |
| Inventory | 529.40M | 513.60M | 533.30M | 555.80M | 535.90M | 538.70M |
| Total assets | 3.00B | 2.98B | 3.03B | 3.06B | 3.09B | 3.99B |
| Total current liabilities | 760.10M | 757.20M | 703.90M | 665.90M | 668.50M | 804.10M |
| Short-term debt | 83.60M | 37.90M | 9.00M | 6.50M | 16.70M | 44.80M |
| Long-term debt | 638.80M | 630.40M | 671.50M | 674.30M | 591.60M | 1.28B |
| Total liabilities | 1,532,300,000.00 | 1,523,700,000.00 | 1,510,200,000.00 | 1,485,300,000.00 | 1,392,200,000.00 | 2,222,400,000.00 |
| Total equity | 1.46B | 1.45B | 1.52B | 1.58B | 1.70B | 1.76B |
| Retained earnings | 2.57B | 2.61B | 2.72B | 2.75B | 2.87B | 2.92B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 345.80M | 387.00M | 401.90M | 252.80M | 544.50M | 492.50M | 418.80M | 493.70M |
| Depreciation & amortization | 81.10M | 87.60M | 95.30M | 93.80M | 92.30M | 98.40M | 99.50M | 106.00M |
| Free cash flow | 195.10M | 262.60M | 342.90M | 167.30M | 426.00M | 406.90M | 339.90M | 426.30M |
| Dividends paid | -99.70M | -106.40M | -107.20M | -110.10M | -114.40M | -122.80M | -131.90M | -141.20M |
| Stock buybacks / issuance | -129.20M | -94.30M | -142.20M | -170.60M | -141.80M | -162.70M | -331.50M | -111.20M |
| Ending cash balance | 177.80M | 236.60M | 222.80M | 193.30M | 187.10M | 232.70M | 180.40M | 250.40M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 87.70M | 167.80M | 125.40M | 33.00M | 135.40M | 199.90M |
| Depreciation & amortization | 24.60M | 24.40M | 24.30M | 24.60M | 24.10M | 33.00M |
| Free cash flow | 71.40M | 149.20M | 111.20M | 18.00M | 112.10M | 185.00M |
| Dividends paid | -32.30M | -35.00M | -34.70M | -34.60M | -34.70M | -37.20M |
| Stock buybacks / issuance | -190.60M | -59.30M | -91.50M | -19.70M | 0 | 0 |
| Ending cash balance | 178.50M | 180.40M | 210.70M | 194.40M | 204.10M | 250.40M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 30.71 | 27.42 | 27.01 | 29.32 | 29.24 | 29.47 | 24.94 | 28.20 |
| ROA %i | 12.97 | 11.72 | 12.35 | 13.31 | 13.36 | 14.57 | 12.46 | 13.03 |
| ROIC %i | 19.27 | 16.83 | 17.70 | 19.97 | 19.88 | 21.52 | 18.57 | 18.49 |
| 5-year avg ROE %i | 25.77 | 26.57 | 27.02 | 27.13 | 28.74 | 28.49 | 28.00 | 28.24 |
| EBIT margin %i | 13.89 | 13.66 | 13.81 | 13.71 | 14.22 | 15.52 | 13.99 | 16.00 |
| FCF / sales %i | 6.86 | 10.17 | 12.02 | 5.06 | 12.42 | 11.35 | 9.21 | 10.97 |
| Current ratioi | 2.32 | 2.70 | 2.05 | 2.23 | 1.70 | 1.84 | 1.93 | 2.08 |
| Quick ratioi | 1.46 | 1.70 | 1.28 | 1.29 | 1.04 | 1.10 | 1.11 | 1.25 |
| Debt / assetsi | 29.72 | 29.07 | 21.23 | 24.92 | 23.67 | 18.42 | 22.45 | 33.23 |
| LT debt / equityi | 65.86 | 62.55 | 40.54 | 56.86 | 37.60 | 32.46 | 43.37 | 72.55 |
| Interest coveragei | 19.85 | 20.26 | 30.31 | 30.42 | 25.41 | 26.01 | 21.34 | 17.27 |
| Revenue CAGR (3Y) %i | 8.61 | 2.87 | 1.44 | 5.14 | 9.94 | 7.91 | 3.73 | 4.24 |
| Net income CAGR (3Y) %i | 11.88 | 3.35 | 16.75 | 7.59 | 11.77 | 13.00 | 3.31 | 8.14 |
| FCF CAGR (3Y) %i | -3.69 | 1.40 | 27.51 | -5.00 | 17.50 | 5.87 | 26.65 | 0.02 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 24.58 | 24.94 | 24.96 | 24.27 | 27.78 | 28.20 |
| ROA %i | 12.36 | 12.46 | 12.58 | 12.57 | 14.42 | 13.03 |
| ROIC %i | 17.94 | 18.57 | 18.31 | 18.25 | 20.52 | 18.49 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.83 | 13.99 | 14.36 | 14.08 | 15.68 | 16.00 |
| FCF / sales %i | 8.19 | 9.21 | 10.82 | 9.32 | 10.26 | 10.97 |
| Current ratioi | 1.94 | 1.93 | 2.15 | 2.29 | 2.35 | 2.08 |
| Quick ratioi | 1.11 | 1.11 | 1.23 | 1.26 | 1.36 | 1.25 |
| Debt / assetsi | 24.11 | 22.45 | 22.48 | 22.25 | 19.70 | 33.23 |
| LT debt / equityi | 43.63 | 43.37 | 44.28 | 42.81 | 34.90 | 72.55 |
| Interest coveragei | 22.51 | 21.34 | 20.74 | 19.14 | 21.02 | 17.27 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Mobile Solutions Segment is the largest reported line at 62.27% of revenue, across 3 reported segments.
- Industrial Solutions segment follows at 29.15%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Mobile Solutions Segment62.27%
Industrial Solutions segment29.15%
Life Sciences segment8.58%
Region
United States (U.S) and Canada42.52%
Europe, Middle East and Africa (EMEA)29.24%
Asia Pacific (APAC)17.75%
Latin America (LatAm)10.50%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.